{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:26:50Z","timestamp":1782487610354,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010937","name":"St. John's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bcp.2021.114823","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T17:37:18Z","timestamp":1636133838000},"page":"114823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Activation of activator protein-1-fibroblast growth factor 21 signaling attenuates Cisplatin hepatotoxicity"],"prefix":"10.1016","volume":"194","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Yarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2021.114823_b0015","doi-asserted-by":"crossref","unstructured":"Kang SG, Choi MJ, Jung SB, Chung HK, Chang JY, Shong M, et al. Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response. iScience. 2021;24(3):102181.","DOI":"10.1016\/j.isci.2021.102181"},{"issue":"23","key":"10.1016\/j.bcp.2021.114823_b0020","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tem.2010.11.003","article-title":"FGF21 reloaded: challenges of a rapidly growing field","volume":"22","author":"Kharitonenkov","year":"2011","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov."},{"issue":"26","key":"10.1016\/j.bcp.2021.114823_b0035","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.taap.2014.04.013","article-title":"Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR)","volume":"278","author":"Cheng","year":"2014","journal-title":"Toxicol Appl Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114823_b0045","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/hep.27719","article-title":"Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21","volume":"61","author":"Lu","year":"2015","journal-title":"Hepatology."},{"key":"10.1016\/j.bcp.2021.114823_b0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2017.01.009","article-title":"Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction","volume":"378","author":"Vispute","year":"2017","journal-title":"Toxicology."},{"key":"10.1016\/j.bcp.2021.114823_b0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.13005\/bpj\/1608","article-title":"Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin","volume":"12","author":"Aldossary","year":"2019","journal-title":"Biomed Pharmacol J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(78)90825-2","article-title":"Platinum nephrotoxicity","volume":"65","author":"Madias","year":"1978","journal-title":"Am J Med."},{"issue":"12","key":"10.1016\/j.bcp.2021.114823_b0070","first-page":"2125","article-title":"A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment","volume":"62","author":"Cavalli","year":"1978","journal-title":"Cancer Treat Rep."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1200\/JCO.1987.5.2.318","article-title":"Cisplatin-induced hepatic toxicity","volume":"5","author":"Pollera","year":"1987","journal-title":"J Clin Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114823_b0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/106002809302700408","article-title":"Hepatotoxicity associated with cisplatin chemotherapy","volume":"27","author":"Cersosimo","year":"1993","journal-title":"Ann Pharmacother."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0085","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0041-008X(83)90266-1","article-title":"The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function","volume":"69","author":"Goldstein","year":"1983","journal-title":"Toxicol Appl Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0090","first-page":"36","article-title":"Cisplatin-induced hyperglycemic hyperosmolar coma","volume":"65","author":"Komdeur","year":"2007","journal-title":"Neth J Med."},{"issue":"12","key":"10.1016\/j.bcp.2021.114823_b0095","first-page":"1409","article-title":"Safe, rapid administration of cisplatin in the outpatient clinic","volume":"70","author":"Brock","year":"1986","journal-title":"Cancer Treat Rep."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0100","first-page":"55","article-title":"Treatment results of VIP (etoposide, ifosfamide and cisplatin) chemotherapy as a first-line therapy in metastatic germ cell tumors","volume":"91","author":"Yoshida","year":"2000","journal-title":"Nihon Hinyokika Gakkai Zasshi."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00257239","article-title":"Human tissue distribution of platinum after cis-diamminedichloroplatinum","volume":"10","author":"Stewart","year":"1982","journal-title":"Cancer Chemother Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.freeradbiomed.2011.11.001","article-title":"Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy","volume":"52","author":"Mukhopadhyay","year":"2012","journal-title":"Free Radic Biol Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114823_b0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00204-014-1239-1","article-title":"Mitochondrial dysregulation and protection in cisplatin nephrotoxicity","volume":"88","author":"Yang","year":"2014","journal-title":"Arch Toxicol."},{"key":"10.1016\/j.bcp.2021.114823_b0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2013.10.008","article-title":"The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting","volume":"722","author":"Chu","year":"2014","journal-title":"Eur J Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114823_b0125","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1096\/fj.201701316R","article-title":"FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury","volume":"32","author":"Li","year":"2018","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.bcp.2021.114823_b0130","doi-asserted-by":"crossref","first-page":"e84058","DOI":"10.1371\/journal.pone.0084058","article-title":"Histopathological analysis of Salmonella chronic carriage in the mouse hepatopancreatobiliary system","volume":"8","author":"Gonzalez-Escobedo","year":"2013","journal-title":"PLoS One."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.107.135822","article-title":"NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet","volume":"325","author":"Tanaka","year":"2008","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1534\/genetics.105.047035","article-title":"Triglyceride pools, flight and activity variation at the Gpdh locus in Drosophila melanogaster","volume":"172","author":"Merritt","year":"2006","journal-title":"Genetics."},{"issue":"11","key":"10.1016\/j.bcp.2021.114823_b0145","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1074\/jbc.M116.757567","article-title":"Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter","volume":"292","author":"Bu","year":"2017","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2021.114823_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00193","article-title":"Fibroblast Growth Factor Signaling in Metabolic Regulation","volume":"6","author":"Nies","year":"2016","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"37","key":"10.1016\/j.bcp.2021.114823_b0155","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2021.114823_b0160","doi-asserted-by":"crossref","unstructured":"Yie J, Wang W, Deng L, Tam LT, Stevens J, Wang M, et al. Understanding the physical interactions in the FGF21\/FGFR\/\u03b2-Klotho complex: structural requirements and implications in FGF21 signaling. Chem Biol Drug Des. 2012;79(4):398-410.","DOI":"10.1111\/j.1747-0285.2012.01325.x"},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0165","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.27147","article-title":"Fibroblast growth factor 21: a new liver safeguard","volume":"60","author":"Cariello","year":"2014","journal-title":"Hepatology."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.freeradbiomed.2011.04.038","article-title":"Salubrinal, an eIF2\u03b1 dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model","volume":"51","author":"Wu","year":"2011","journal-title":"Free Radic Biol Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/BJ20111748","article-title":"Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation","volume":"443","author":"De Sousa-Coelho","year":"2012","journal-title":"Biochem J."},{"key":"10.1016\/j.bcp.2021.114823_b0180","first-page":"1","article-title":"ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress","volume":"2014","author":"Wan","year":"2014","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.bcp.2021.114823_b0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cellsig.2017.08.009","article-title":"Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevity","volume":"40","author":"Salminen","year":"2017","journal-title":"Cell Signal."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0190","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2017.07.007","article-title":"mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression","volume":"26","author":"Khan","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jcb.25619","article-title":"Specificity of Stress-Responsive Transcription Factors Nrf2, ATF4, and AP-1","volume":"118","author":"R\u00f6ssler","year":"2017","journal-title":"J Cell Biochem."},{"issue":"16","key":"10.1016\/j.bcp.2021.114823_b0200","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1)","volume":"57","author":"Ye","year":"2014","journal-title":"J Med Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0205","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s000180050302","article-title":"Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells","volume":"55","author":"Li","year":"1999","journal-title":"Cell Mol Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bcp.2021.114823_b0215","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/bcp.12676","article-title":"Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study","volume":"80","author":"Dong","year":"2015","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study","volume":"27","author":"Charles","year":"2019","journal-title":"Obesity (Silver Spring)."},{"issue":"17","key":"10.1016\/j.bcp.2021.114823_b0230","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1073\/pnas.122359899","article-title":"Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"36","key":"10.1016\/j.bcp.2021.114823_b0235","doi-asserted-by":"crossref","first-page":"23419","DOI":"10.1074\/jbc.273.36.23419","article-title":"Cisplatin induction of ERCC-1 mRNA expression in A2780\/CP70 human ovarian cancer cells","volume":"273","author":"Li","year":"1998","journal-title":"J Biol Chem."},{"issue":"18","key":"10.1016\/j.bcp.2021.114823_b0240","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bcp.2021.114823_b0245","doi-asserted-by":"crossref","unstructured":"Wu F, Wang B, Zhang S, Shi L, Wang Y, Lin Z, et al. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice. Clin Sci. 2017;131(15):1877-1893.","DOI":"10.1042\/CS20170271"},{"issue":"47","key":"10.1016\/j.bcp.2021.114823_b0250","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1038\/sj.onc.1203060","article-title":"The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells","volume":"18","author":"Zhan","year":"1999","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.bcp.2021.114823_b0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cdd.4400815","article-title":"Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction","volume":"8","author":"Bailly-Maitre","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2021.114823_b0260","doi-asserted-by":"crossref","unstructured":"Zhu Y, Bi F, Li Y, Yin H, Deng N, Xiao B, et al. \u03b1- and \u03b2-Naphthoflavone synergistically attenuate H2O2-induced neuron SH-SY5Y cell damage. Exp Ther Med. 2017;13(3):1143-1150.","DOI":"10.3892\/etm.2017.4045"},{"issue":"1-2","key":"10.1016\/j.bcp.2021.114823_b0265","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11010-015-2358-6","article-title":"Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K\/Akt pathways","volume":"403","author":"Yu","year":"2015","journal-title":"Mol Cell Biochem."},{"key":"10.1016\/j.bcp.2021.114823_b0270","doi-asserted-by":"crossref","first-page":"113007","DOI":"10.1016\/j.expneurol.2019.113007","article-title":"Delayed recanalization at 3 days after permanent MCAO attenuates neuronal apoptosis through FGF21\/FGFR1\/PI3K\/Caspase-3 pathway in rats","volume":"320","author":"Zheng","year":"2019","journal-title":"Exp Neurol."},{"key":"10.1016\/j.bcp.2021.114823_b0275","doi-asserted-by":"crossref","unstructured":"Omar HA, Mohamed WR, Arab HH, Arafa el-SA. Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis. PLoS One. 2016;11(3):e0151649.","DOI":"10.1371\/journal.pone.0151649"},{"issue":"4","key":"10.1016\/j.bcp.2021.114823_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22714","article-title":"Hepatoprotective effect of arjunolic acid against cisplatin-induced hepatotoxicity: Targeting oxidative stress, inflammation, and apoptosis","volume":"35","author":"Sherif","year":"2021","journal-title":"J Biochem Mol Toxicol."},{"key":"10.1016\/j.bcp.2021.114823_b0285","first-page":"217","article-title":"Saunders Handbook of Veterinary Drugs","author":"Dexamethasone","year":"2016","journal-title":"(Fourth Edition)"},{"issue":"9","key":"10.1016\/j.bcp.2021.114823_b0290","doi-asserted-by":"crossref","first-page":"e0204336","DOI":"10.1371\/journal.pone.0204336","article-title":"Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation","volume":"13","author":"Gabbia","year":"2018","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0295","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1038\/s41467-021-24847-6","article-title":"How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer","volume":"12","author":"Clarisse","year":"2021","journal-title":"Nat Commun."},{"issue":"7749","key":"10.1016\/j.bcp.2021.114823_b0300","first-page":"540","article-title":"M\u221a\u00b0nst S, Okamoto R, Kohler H, Schmidt A, Bentires-Alj M","volume":"567","author":"Obradovi\u0107","year":"2019","journal-title":"Glucocorticoids promote breast cancer metastasis. Nature."},{"key":"10.1016\/j.bcp.2021.114823_b0305","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun."},{"issue":"8","key":"10.1016\/j.bcp.2021.114823_b0310","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EC-20-0152","article-title":"FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation","volume":"9","author":"Keinicke","year":"2020","journal-title":"Endocr Connect."},{"issue":"2","key":"10.1016\/j.bcp.2021.114823_b0315","doi-asserted-by":"crossref","first-page":"e0148709","DOI":"10.1371\/journal.pone.0148709","article-title":"GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction","volume":"11","author":"Montero","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.bcp.2021.114823_b0320","doi-asserted-by":"crossref","first-page":"17238","DOI":"10.1038\/s41598-017-17574-w","article-title":"GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury","volume":"7","author":"Chung","year":"2017","journal-title":"Sci Rep."},{"issue":"11","key":"10.1016\/j.bcp.2021.114823_b0325","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.molmet.2017.08.004","article-title":"Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury","volume":"6","author":"Desai","year":"2017","journal-title":"Mol Metab."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:26:46Z","timestamp":1757770006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":65,"alternative-id":["S0006295221004391"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114823","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of activator protein-1-fibroblast growth factor 21 signaling attenuates Cisplatin hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114823"}}